Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
Open Access
- 22 August 2013
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 122 (8), 1341-1349
- https://doi.org/10.1182/blood-2013-03-478255
Abstract
Long-term engraftment of allogeneic cells necessitates eluding immune-mediated rejection, which is currently achieved by matching for human leukocyte antigen (HLA) expression, immunosuppression, and/or delivery of donor-derived cells to sanctuary sites. Genetic engineering provides an alternative approach to avoid clearance of cells that are recognized as “non-self” by the recipient. To this end, we developed designer zinc finger nucleases and employed a “hit-and-run” approach to genetic editing for selective elimination of HLA expression. Electro-transfer of mRNA species coding for these engineered nucleases completely disrupted expression of HLA-A on human T cells, including CD19-specific T cells. The HLA-Aneg T-cell pools can be enriched and evade lysis by HLA-restricted cytotoxic T-cell clones. Recognition by natural killer cells of cells that had lost HLA expression was circumvented by enforced expression of nonclassical HLA molecules. Furthermore, we demonstrate that zinc finger nucleases can eliminate HLA-A expression from embryonic stem cells, which broadens the applicability of this strategy beyond infusing HLA-disparate immune cells. These findings establish that clinically appealing cell types derived from donors with disparate HLA expression can be genetically edited to evade an immune response and provide a foundation whereby cells from a single donor can be administered to multiple recipients.Keywords
This publication has 49 references indexed in Scilit:
- Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapyScientific Reports, 2012
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemiasBlood, 2011
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19Blood, 2010
- Derivation of Pre-X Inactivation Human Embryonic Stem Cells under Physiological Oxygen ConcentrationsCell, 2010
- Transient cold shock enhances zinc-finger nuclease–mediated gene disruptionNature Methods, 2010
- C19orf48Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma PatientsClinical Cancer Research, 2008
- Class-, gene-, and group-specific HLA silencing by lentiviral shRNA deliveryJournal of Molecular Medicine, 2006
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005
- HLA compatibility and organ transplant survival. Collaborative Transplant Study.1999
- Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated LysisThe Journal of Experimental Medicine, 1998